RC
Rubric Capital Management LP
€46m
▲ Purchases (14 ops.)
Insider track record Other Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Rubric Capital Management LP. Director active across 4 companies, notably Heron Therapeutics, INC.. In total, 21 disclosures have been published. Breakdown: 14 buys · 2 sells. Total volume traded: €1bn. Activity tracked since 8 December 2021. The latest transaction was disclosed on 13 December 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations 21 total
946,100 shares Common Stock, par value $0.01 per share ("Common Stock") SEC:0000902664-25-004459
946,100 shares Common Stock, par value $0.01 per share ("Common Stock") SEC:0000902664-25-004459:0
4,893,507 shares @ US$204.3524 100.0% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-24-128881:0
877,192 shares @ US$2.28 2.0% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-23-119331:0
312,525 shares @ US$3.6797 1.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-23-076387:0
29,000 shares @ US$1,333.00 39.1% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-23-024323:0
29,000 shares @ US$1,333.00 39.1% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-23-000311:0
14,825 shares @ US$6.09 0.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-126117:0
Ideal exit: 5 Sept 2023 (T+270) 20,113 shares @ US$5.6625 0.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-125712:0
Ideal exit: 3 Sept 2023 (T+270) 7,000 shares @ US$1,000.00 7.6% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-22-112801:0
Ideal exit: 25 Jul 2023 (T+270) 7,000 shares @ US$1,000.00 7.7% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-22-105392:0
Ideal exit: 27 Jun 2023 (T+270) 1,678,954 shares @ US$10.07 57.3% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-22-089894:0
Ideal exit: 8 May 2023 (T+270) 4,012 shares @ US$10.07 0.1% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-22-089124:0
Ideal exit: 7 May 2023 (T+270) 565,000 shares @ US$4.72 2.8% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-084850:0
Ideal exit: 25 Apr 2023 (T+270) 64,892 shares @ US$5.56 0.4% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-080754:0
Ideal exit: 11 Apr 2023 (T+270) 146,685 shares @ US$7.0747 15.1% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150598
Ideal exit: 12 Sept 2022 (T+270) 146,685 shares @ US$7.0747 7.6% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150598:0
Ideal exit: 12 Sept 2022 (T+270) 187,391 shares @ US$7.0804 19.3% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150068
Ideal exit: 9 Sept 2022 (T+270) 187,391 shares @ US$7.0804 9.6% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150068:0
Ideal exit: 9 Sept 2022 (T+270) 560,691 shares @ US$8.0206 65.6% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-148720
Ideal exit: 4 Sept 2022 (T+270) 560,691 shares @ US$8.0206 32.8% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-148720:0
Ideal exit: 4 Sept 2022 (T+270) About Rubric Capital Management LP Rubric Capital Management LP is a director and insider, primarily involved with Heron Therapeutics, INC. and Radius Health, Inc.